Grant: Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
University of Toronto
$105,000.00
The role of Pseudomonas aeruginosa bacteriophages in Cystic Fibrosis: modulation of disease progression and development of phage therapy
EF 2009-10
Résumé
Pseudomonas aeruginosa is a bacterium found in soil and water and is also able to cause human infections. Common P. aeruginosa infections target the lung, urinary tract, eyes, ears and burn wounds. Individuals with Cystic Fibrosis (CF) are highly susceptible to P. aeruginosa infection and once infected, will remain colonized for the rest of their lives. P. aeruginosa is highly resistant to traditional antibiotics and modern therapies provide little relief.
Bacteriophages (phages) are viruses able to infect and kill bacteria. Bacteriophage therapy utilizes this natural process by targeting phages as a therapeutic to treat bacterial infections in humans. Although phage therapy has been used before, it has not been extensively examined with respect to CF. Work proposed here includes elucidating the role that phages naturally play in limiting infections of P. aeruginosa in those with CF. It is proposed that phages naturally act as an antibacterial agent in the lungs of CF patients and if true, this phenomenon could be manifested into a treatment. A link between phage levels in the CF lung and disease has not been examined prior to this work.
This work will be conducted by analyzing lung samples from CF patients and following them over a period of approximately three years. Items to be assessed and compared will include the patient's disease status, bacterial level and presence of phage.
This work is of high importance to the health of Canadians as alternatives to antibiotics are urgently necessary for a number of bacterial infections and this work has broad reaching implications in this field. P. aeruginosa causes a number of infections but specifically with respect to the 3,500 Canadians living with CF, this work stands to benefit them directly. Furthermore, these studies will serve to enhance our understanding of phage biology and its link with human disease.
Programme
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
206084
Name
Bondy-Denomy Joseph W
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
The role of Pseudomonas aeruginosa bacteriophages in Cystic Fibrosis: modulation of disease progression and development of phage therapy
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Keyworddelim
Antibiotic Resistance; Bacterial Virulence Factors; Bacteriophage; Cystic Fibrosis; Lung Infections; Phage Therapy; Pseudomonas Aeruginosa; Wound Infections
Abstract
Pseudomonas aeruginosa is a bacterium found in soil and water and is also able to cause human infections. Common P. aeruginosa infections target the lung, urinary tract, eyes, ears and burn wounds. Individuals with Cystic Fibrosis (CF) are highly susceptible to P. aeruginosa infection and once infected, will remain colonized for the rest of their lives. P. aeruginosa is highly resistant to traditional antibiotics and modern therapies provide little relief.
Bacteriophages (phages) are viruses able to infect and kill bacteria. Bacteriophage therapy utilizes this natural process by targeting phages as a therapeutic to treat bacterial infections in humans. Although phage therapy has been used before, it has not been extensively examined with respect to CF. Work proposed here includes elucidating the role that phages naturally play in limiting infections of P. aeruginosa in those with CF. It is proposed that phages naturally act as an antibacterial agent in the lungs of CF patients and if true, this phenomenon could be manifested into a treatment. A link between phage levels in the CF lung and disease has not been examined prior to this work.
This work will be conducted by analyzing lung samples from CF patients and following them over a period of approximately three years. Items to be assessed and compared will include the patient's disease status, bacterial level and presence of phage.
This work is of high importance to the health of Canadians as alternatives to antibiotics are urgently necessary for a number of bacterial infections and this work has broad reaching implications in this field. P. aeruginosa causes a number of infections but specifically with respect to the 3,500 Canadians living with CF, this work stands to benefit them directly. Furthermore, these studies will serve to enhance our understanding of phage biology and its link with human disease.
Competitiondate
200910
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Bondy-Denomy, Joseph W
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~